Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans.

Atochina-Vasserman EN, Winkler C, Abramova H, Schaumann F, Krug N, Gow AJ, Beers MF, Hohlfeld JM.

Am J Respir Crit Care Med. 2011 Apr 1;183(7):856-64. doi: 10.1164/rccm.201004-0654OC. Epub 2010 Dec 3.

2.

Signaling pathways in the epithelial origins of pulmonary fibrosis.

Hardie WD, Hagood JS, Dave V, Perl AK, Whitsett JA, Korfhagen TR, Glasser S.

Cell Cycle. 2010 Jul 15;9(14):2769-76. Epub 2010 Jul 3. Review.

3.

Review: Chemical and structural modifications of pulmonary collectins and their functional consequences.

Atochina-Vasserman EN, Beers MF, Gow AJ.

Innate Immun. 2010 Jun;16(3):175-82. doi: 10.1177/1753425910368871. Epub 2010 Apr 27. Review.

4.

Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia.

Mahavadi P, Korfei M, Henneke I, Liebisch G, Schmitz G, Gochuico BR, Markart P, Bellusci S, Seeger W, Ruppert C, Guenther A.

Am J Respir Crit Care Med. 2010 Jul 15;182(2):207-19. doi: 10.1164/rccm.200909-1414OC. Epub 2010 Apr 8.

5.

Pulmonary surfactant: an immunological perspective.

Chroneos ZC, Sever-Chroneos Z, Shepherd VL.

Cell Physiol Biochem. 2010;25(1):13-26. doi: 10.1159/000272047. Epub 2009 Dec 22. Review.

6.

Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis.

Sisson TH, Mendez M, Choi K, Subbotina N, Courey A, Cunningham A, Dave A, Engelhardt JF, Liu X, White ES, Thannickal VJ, Moore BB, Christensen PJ, Simon RH.

Am J Respir Crit Care Med. 2010 Feb 1;181(3):254-63. doi: 10.1164/rccm.200810-1615OC. Epub 2009 Oct 22.

7.

Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1.

Rouhani FN, Brantly ML, Markello TC, Helip-Wooley A, O'Brien K, Hess R, Huizing M, Gahl WA, Gochuico BR.

Am J Respir Crit Care Med. 2009 Dec 1;180(11):1114-21. doi: 10.1164/rccm.200901-0023OC. Epub 2009 Sep 3.

8.

Protein S-nitrosylation in health and disease: a current perspective.

Foster MW, Hess DT, Stamler JS.

Trends Mol Med. 2009 Sep;15(9):391-404. doi: 10.1016/j.molmed.2009.06.007. Epub 2009 Aug 31. Review.

9.

Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.

Atochina-Vasserman EN, Gow AJ, Abramova H, Guo CJ, Tomer Y, Preston AM, Beck JM, Beers MF.

J Immunol. 2009 Feb 15;182(4):2277-87. doi: 10.4049/jimmunol.0802775.

10.

Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo.

Matalon S, Shrestha K, Kirk M, Waldheuser S, McDonald B, Smith K, Gao Z, Belaaouaj A, Crouch EC.

FASEB J. 2009 May;23(5):1415-30. doi: 10.1096/fj.08-120568. Epub 2009 Jan 6.

11.

Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis.

Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA, Chapman HA.

J Clin Invest. 2009 Jan;119(1):213-24. doi: 10.1172/JCI36940. Epub 2008 Dec 22.

12.

S-nitrosylation of surfactant protein-D controls inflammatory function.

Guo CJ, Atochina-Vasserman EN, Abramova E, Foley JP, Zaman A, Crouch E, Beers MF, Savani RC, Gow AJ.

PLoS Biol. 2008 Nov 11;6(11):e266. doi: 10.1371/journal.pbio.0060266.

13.

Surfactant protein D protects against acute hyperoxic lung injury.

Jain D, Atochina-Vasserman EN, Tomer Y, Kadire H, Beers MF.

Am J Respir Crit Care Med. 2008 Oct 15;178(8):805-13. doi: 10.1164/rccm.200804-582OC. Epub 2008 Jul 17.

14.

Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics.

Huizing M, Helip-Wooley A, Westbroek W, Gunay-Aygun M, Gahl WA.

Annu Rev Genomics Hum Genet. 2008;9:359-86. doi: 10.1146/annurev.genom.9.081307.164303. Review.

15.

Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis.

Young LR, Pasula R, Gulleman PM, Deutsch GH, McCormack FX.

Am J Respir Cell Mol Biol. 2007 Jul;37(1):67-74. Epub 2007 Mar 15.

16.

Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase.

Korhonen R, Linker K, Pautz A, Förstermann U, Moilanen E, Kleinert H.

Mol Pharmacol. 2007 May;71(5):1427-34. Epub 2007 Feb 22.

17.

Induction of monocyte chemoattractant protein-1 release from A549 cells by agonists of protease-activated receptor-1 and -2.

Wang H, Yi T, Zheng Y, He S.

Eur J Cell Biol. 2007 Apr;86(4):233-42. Epub 2007 Feb 5.

PMID:
17280738
18.

Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.

Selman M, Pardo A.

Proc Am Thorac Soc. 2006 Jun;3(4):364-72. Review.

PMID:
16738202
19.

Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome.

Young LR, Borchers MT, Allen HL, Gibbons RS, McCormack FX.

J Immunol. 2006 Apr 1;176(7):4361-8.

20.

Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.

Santiago Borrero PJ, Rodríguez-Pérez Y, Renta JY, Izquierdo NJ, Del Fierro L, Muñoz D, Molina NL, Ramírez S, Pagán-Mercado G, Ortíz I, Rivera-Caragol E, Spritz RA, Cadilla CL.

J Invest Dermatol. 2006 Jan;126(1):85-90.

Supplemental Content

Support Center